{
  "id": "enwiki-001359352942",
  "slug": "calysta",
  "title": "Calysta",
  "qid": "",
  "lead": "Calysta is a privately held biotechnology company based in California that develops and commercializes microbial protein ingredients through gas-fermentation technology for use in animal feed and other food applications. Calysta uses methanotrophic bacteria to ferment methane into single-cell protein ingredients designed for aquaculture and livestock feed applications. It also uses other food ingredients. Beginning in 2016, Calysta had operated a demonstration plant in Teesside, England, that used methanotroph bacteria to convert methane into FeedKind® single cell protein under a UK government grant. The product received approval for inclusion in fish and livestock feed in the European Union. The facility was later decommissioned as the company shifted away from pilot-scale operations. Calysta was founded in 2012, based on technology developed by scientists associated with DNA2.0 (now ATUM), a US synthetic biology company. Calysta secured venture funding to commercialize its methane-to-protein technology.",
  "body": "Calysta is a privately held biotechnology company based in California that develops and commercializes microbial protein ingredients through gas-fermentation technology for use in animal feed and other food applications. Calysta uses methanotrophic bacteria to ferment methane into single-cell protein ingredients designed for aquaculture and livestock feed applications. It also uses other food ingredients. Beginning in 2016, Calysta had operated a demonstration plant in Teesside, England, that used methanotroph bacteria to convert methane into FeedKind® single cell protein under a UK government grant. The product received approval for inclusion in fish and livestock feed in the European Union. The facility was later decommissioned as the company shifted away from pilot-scale operations. Calysta was founded in 2012, based on technology developed by scientists associated with DNA2.0 (now ATUM), a US synthetic biology company. Calysta secured venture funding to commercialize its methane-to-protein technology.",
  "categories": [
    "115619803",
    "22906783",
    "23147661",
    "23603337",
    "24043274",
    "24745107",
    "26095571",
    "26220375",
    "26748027",
    "42161628",
    "5284565",
    "7403311",
    "90431561"
  ],
  "license": "CC BY-SA 4.0",
  "source_uri": "https://en.wikipedia.org/w/index.php?oldid=1359352942",
  "content_hash": "",
  "created_at": null,
  "updated_at": 1781458718.0,
  "claims": [
    {
      "id": 32975167,
      "subject_qid": "",
      "subject_slug": "calysta",
      "predicate": "date of foundation",
      "object_text": "2012",
      "object_num": 20120000.0,
      "object_unit": null,
      "polarity": 1,
      "qualifier": "",
      "source_uri": "https://en.wikipedia.org/w/index.php?oldid=1359352942",
      "source_name": "Wikipedia",
      "source_tier": 3,
      "retrieved_at": 1792528209.5335839,
      "confidence": 0.95,
      "article_slug": "calysta",
      "span_start": 12,
      "span_end": 59
    }
  ],
  "contradictions": [],
  "confidence": 0.95,
  "csl": {
    "id": "enwiki-001359352942",
    "type": "webpage",
    "title": "Calysta",
    "author": [
      {
        "family": "Anticloud FZ LLE",
        "literal": "Anticloud FZ LLE"
      }
    ],
    "container-title": "encyclopegia.org",
    "publisher": "Anticloud FZ LLE",
    "publisher-place": "Dubai, United Arab Emirates",
    "URL": "https://encyclopegia.org/a/calysta",
    "issued": {
      "date-parts": [
        [
          2026,
          11,
          19
        ]
      ]
    },
    "accessed": {
      "date-parts": [
        [
          2026,
          11,
          19
        ]
      ]
    },
    "license": "CC BY-SA 4.0",
    "DOI": "eo1:enwiki-001359352942",
    "isBasedOn": "https://en.wikipedia.org/w/index.php?oldid=1359352942",
    "note": "Immutable snapshot enwiki-001359352942"
  }
}